ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0007252;I-kappaB phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.292166977892469;0.006049650283656873;0.747921758369865;[CHUK, TLR7, TLR4, TLR2]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[ORM1, FZD5, RIPK2, NOD2, PYCARD, NLRP12, TLR8, NLRP3, CCL19, TLR4]
GO:0002480;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;6.0;1.0;0.8231203125901445;9.628524252492122;33.24930607151726;7.57984905034425;0.0011128243517809471;0.710754145523778;[HLA-B, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, IL18, ACTN4, GREM1, IL23A, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, NOD2, CCL19, CD14, TNFSF14, TNFRSF10B, EIF2AK2, NLRP12, CD27, IL18R1]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, ARRB1, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, RIPK2, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;6.0;1.0;0.8231203125901445;9.628524252492122;33.24930607151726;6.518977089658987;0.0011128243517809471;0.6565011041187423;[CHUK, ITGB5, HLA-B, TAP1, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E, CD36, FCGR1A, FCGR1B]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[LY96, HSPD1, CD36, CD14, IRAK3, TLR1, BTK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, MYD88, TLR2]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, STAT4, SPP1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, RUVBL2, ADCYAP1, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, ARRB1, HHEX, PPP1R12A, PEG3, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, CCNH, IKZF1, TNFSF11, HNF1B, SFRP2, EGR1, EGR2, EGR3, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3D, HNF4A, CD38, IL10, IL18, RGMA, IL1A, IL1B, YAP1, SATB2, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, EOMES, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, ETV1, CCNA2, GREM1, PSRC1, ELF3, IRF7, CREB5, TAF9, TBX21, EGF, MAPK14, CD4, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAX5, PAX2, RARA, PLCB1, ENG, NR1I2, EPCAM, NR1H2, NR1H4, GTF2H1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, DAB2, COPS5, MAFB, MAFF, BCL3, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR4, TLR2, SP100, CDX2, CDX1, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, KLF13, CKAP2, DCN, DNM2, LEF1, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, RIPK2, SLC11A1, IL18, IL23A, IL1B, LTA, TLR8, TLR7, TLR4, TXK, RASGRP1, HSPD1, KLRK1, CD14, IL12RB1, IL12RB2, FZD5, CD2, BCL3, HLA-DPB1, IL18R1, CD244]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[CSF1R, TWIST1, TNF, PYCARD, HMOX1, FFAR2, IL6R, HAVCR2, EGR1, CD74, IL33, POSTN, RIPK2, EIF2AK2, AZU1, MIF, ADCYAP1, IL1A, IL6, IL1B, TLR7, TLR4, TLR2]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, CAMP, HAVCR2, RIPK2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, HLA-E, FGR, IL6, LTA, MYD88, TLR2]
GO:0070206;protein trimerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.8650506222523235;0.00140677858073304;0.6230592741648748;[MGST1, TCL1A, NUP62, EMILIN1, CD74, ARG1, MIF, COL1A1, COL1A2, COL6A2, COL6A1, NUP54, CD247]
GO:0035397;helper T cell enhancement of adaptive immune response;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;141.16491257062583;9.777073627680469;0.004724662583565679;0.875;[CD4]
GO:0043518;negative regulation of DNA damage response, signal transduction by p53 class mediator;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;408.0520127891259;7.138016298065211;0.013657133645082668;0.7612791106150483;[CD74, TWIST1, SNAI2, MIF, SIRT1]
GO:0030260;entry into host cell;6.0;0.7369933605727446;0.6916169928765168;8.68406264365127;26.98811751292015;5.212725436212633;9.032680054285688E-4;0.5896993338145817;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, CDH1, ANPEP, CLEC5A, ITGB7, ITGB6, CCR5, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, CXCR4, DPP4, NCAM1, SLAMF1, GPR15, CD4, CDK1]
GO:1902166;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;11.0;1.0;0.9324289523296623;9.628524252492122;2131.9864477698584;7.212124270218933;0.07135566774362433;0.8012573229067359;[CD74, TAF9, MIF, SIRT1]
GO:2001183;negative regulation of interleukin-12 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;8.67846133901236;0.02523477878196853;0.8590579283277371;[TLR8, LILRB1]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[SERPINE1, TNF, ETS1, TNFSF11, FFAR2, CCR7, CCR2, FCER1G, IL18, IL17RB, IL23A, IL1B, BTK, AGTR1, LTA, TLR10, TLR7, ADAM8, TLR6, TLR4, S100A9, S100A8, TLR2, SUCNR1, TNFRSF11A, NOD2, PTGS2, PLA2G7, C3, CNR1, CCL4, S100A12, CCL18, SNCA, IL33, CCL23, OSM, MAPK13, NFKBIA, NLRP12, IL6, CD6, CD28, MYD88, IL17A]
GO:0045416;positive regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.474488534686424;0.027942676825076673;0.7572456912631272;[TLR8, TLR7, TLR4, TNF, ELANE]
GO:0045657;positive regulation of monocyte differentiation;9.0;1.0;0.896240625180289;9.628524252492122;840.3783565179247;7.57984905034425;0.02812670730123667;0.7838744581139225;[CD74, CD4, JUN, ACIN1]
GO:0097011;cellular response to granulocyte macrophage colony-stimulating factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;7.57984905034425;0.0027327542132076126;0.710754145523778;[CD4, AKT1]
GO:0042270;protection from natural killer cell mediated cytotoxicity;10.0;1.0;0.9152410118609203;9.628524252492122;432.7546622253915;8.67846133901236;0.014483909090773338;0.8590579283277371;[SERPINB9, HLA-E]
GO:0002767;immune response-inhibiting cell surface receptor signaling pathway;7.0;0.811012628672052;0.7564256795932265;9.249034630787218;128.36963739579423;7.9853141584524145;0.004296416238464106;0.7592887026755414;[LYN, CLEC12B, LILRB1, LILRB2, KIR2DL1, HLA-G]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, TNFSF13B, CD38, NCKAP1L, CD74, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, BCL2, CARD11, CD320]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, SECTM1, FASLG, NUP62, CCR7, CD36, CHUK, RIPK2, ZDHHC17, IL1B, TLR6, BIRC2, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, LTBR]
GO:0046598;positive regulation of viral entry into host cell;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;85.02443603688559;7.57984905034425;0.0028456913571300335;0.7626338329336335;[CD74, CD4, LGALS1, TMPRSS2]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[TREM2, CD3E, TNF, JPH2, CCL4, SYK, TRAT1, ZAP70, P2RX5, CD4, CALM3]
GO:0002455;humoral immune response mediated by circulating immunoglobulin;7.0;1.0;0.8509193652572005;9.628524252492122;48.293467131004675;8.390779266560578;0.001616338883576055;0.7800242071602487;[EXO1, BCL3, HLA-DQB1]
GO:0051024;positive regulation of immunoglobulin secretion;9.0;1.0;0.896240625180289;9.628524252492122;579.4559284816147;7.379178354882098;0.019393868449801132;0.7736121494158466;[IL33, IL6, HLA-E]
GO:2000778;positive regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.0674169630446;6.599019797332524;0.02068616022119099;0.7527151911823093;[DDX58, F2R, TWIST1, PYCARD, IFIH1, IL1B, TLR8, IL17A]
GO:0019064;fusion of virus membrane with host plasma membrane;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;56.73089801191601;7.8311634786251565;0.0018987321019653565;0.7514054297404357;[CD4, CXCR4, CCR5]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PDGFA, BMI1, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, CD74, JUN, TGFB1, FN1, CDC6, MIF, PML, EREG, BTC, CCNA2, NDUFS4]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CSF3, NCF1, CD80, ITGB3, IFNA2, TREM2, ARRB2, CD3E, GHR, GRM5, CD36, IL6R, SYK, RIPK2, IL18, MIF, PARP9, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HBEGF, CSF1R, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, CD74, TGFB1, ACE, EGF, LIF, OSM, GH1, CD4, IL6, CSPG4, CD24]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, PIK3CD, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, RIPK2, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, TXK, GATA3, THY1, PAK1, INPP5D, PLCG2, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, BTNL8, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, LAT, HLA-DRB1]
GO:0034162;toll-like receptor 9 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;7.004484905440688;0.013811191226989502;0.8063299963962409;[UNC93B1, NR1H4, TLR8, TLR7, MYD88, HAVCR2]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[TNF, AKT1, CHUK, RIPK2, BTK, TLR8, TLR7, TLR4, CARD11, BIRC2, BIRC3, LY96, NLRC3, CD14, CARD9, NFKB1, NFKB2, NFKBIA, BCL3]
GO:0002476;antigen processing and presentation of endogenous peptide antigen via MHC class Ib;5.0;0.8653626801206646;0.7229223519212526;9.405380701177911;42.20009821028515;7.697632086000634;0.0014123993094755708;0.6838982747154925;[HLA-B, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[CX3CR1, IL33, JUN, ITGAM, ITGB2, FPR2, AZU1, CLU, AIF1, TLR8, TLR7, TLR6, TLR2, SNCA]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0002503;peptide antigen assembly with MHC class II protein complex;7.0;1.0;0.8509193652572005;9.628524252492122;45.61567929762514;8.67846133901236;0.0015267157346454312;0.7947362817240173;[HLA-DMA, HLA-DMB, HLA-DRA]
GO:0001932;regulation of protein phosphorylation;8.0;0.49565848909023646;0.6228292445451182;7.636094087801916;109.02632868365667;2.531418560085934;0.00364901310371649;0.5044568628857964;[, PID1, ADARB1, PHB2, AKT1, PROK2, ROPN1L, PRKACB, PRKCE, PRKCD, PRKAR1B, ATF3, FPR1, PDGFA, FPR2, THY1, SLC30A10, IQGAP3, GATA1, PRKCZ, C3, FLRT2, PRKAR2B, PDGFD, PDGFC, S100A12, SFN, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FN1, FZD8, EIF2AK2, CDC6, AZU1, NR2F2, NOX4, PKIG, NOX1, EZH2, CDKN1A, LRRC4, TIMP2, TIMP3, HAVCR2, DUSP2, GPR37, DUSP3, DUSP1, RIPK2, FCRL3, BGN, SIRT1, DUSP6, CKS2, PLCB1, HBEGF, ENG, CCL13, LRRC19, FAM129A, PTGS2, GPNMB, NTF3, DMD, CCL19, CCL18, CCL23, CDKN2C, CCL21, CCL20, CARD9, GTF2H1, ELP4, CENPE, PKN1, CSF3, CCNT2, NCF1, FMR1, TNF, CLU, CTGF, PYCARD, MEN1, IFNA14, MAP2K2, CISH, IFNA16, IGFBP3, F2R, CDC25A, ADCYAP1, ADAM9, ADAM8, IFNA10, CSF1R, BLM, TNFRSF11A, PKMYT1, FOXO1, SOCS2, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, CXCL10, DAB2, COPS5, PTPRC, CDK1, BCL2, PLXNB2, CSPG4, LAT, LRRK2, ITGB3, ITGB2, TREM2, PTPN22, ARRB1, ARRB2, CYR61, HHEX, DUSP10, EMILIN1, XCL2, XCL1, LCP2, CEBPA, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, KLF4, PML, RAD50, PTPN6, FCGR2B, PPIL4, IL1RN, CCNH, HERC5, TCL1A, EDNRB, PPP2R1A, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, PAQR3, FLT3LG, MIF, EREG, SFRP2, IL23A, TRIB1, EPHA3, EPHA2, TGFA, TWIST1, PIK3R5, PKHD1, SLAMF1, CCR1, EGR1, LIF, PTK2, BST1, MARCO, ID1, CD27, CALM3, CD24, IFNA5, IFNA4, NRP1, IFNA7, PTPRR, CD40, IFNA2, CD3E, IFNA8, RAC2, CCR7, CD36, MAP4K1, EDN1, SYK, STRADB, IL18, GP1BA, PARP9, CEACAM1, MDFIC, BANK1, IL1B, KIT, TLR8, TLR7, TLR6, TLR4, CXCR4, AIF1, GNAI2, PAK1, CD74, OSM, PODN, NLRP12, CD40LG, CAMK1, CD80, IL6R, PDGFRB, PDGFRA, TSC2, CCNE2, HGS, CCNE1, CALCA, C5AR1, FBLN1, ADRB2, RASGRP1, CCNB2, CCNB1, HRH4, STAP1, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GNAQ, TNFAIP3, GHR, GRM5, LRRTM4, NUP62, MYOCD, PLAUR, IRAK3, AXIN2, MMP9, DCN, FGR, CCNA2, GREM1, PSRC1, IFNG, NDUFS4, CHI3L1, PDE5A, ZMYND11, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[CD74, FCER1G, PRKCD, EXO1, INPP5D, BCL3, IRF7, TLR8, CD27, FCGR2B, IL13RA2, HLA-DQB1]
GO:0006948;induction by virus of host cell-cell fusion;8.0;1.0;0.875;9.628524252492122;77.37443216443229;9.777073627680469;0.0025896526120755235;0.875;[CD4]
GO:0002506;polysaccharide assembly with MHC class II protein complex;6.0;1.0;0.8231203125901445;9.628524252492122;58.63041707748974;9.083926447120524;0.0019623072956339374;0.7876727335416686;[HLA-DRA, HLA-DRB1]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, SIRPA, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, DOK2, PRTN3, ADAM8, S100A9, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, ESAM, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, PIK3CD, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, SLC7A9, IL1B, CEACAM5, KIT, PECAM1, XCL2, XCL1, CEACAM8, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR3, TBX21, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0019731;antibacterial humoral response;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;115.72816977122699;6.221725566191056;0.0038733176936520722;0.6690987000520388;[IGHM, DEFA4, HIST1H2BK, RNASE6, RNASE3, DEFA1, HLA-E, SLPI, CTSG, IGHA1, IGKV3-20, CAMP, LTF]
GO:0034158;toll-like receptor 8 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;9.777073627680469;0.013811191226989502;0.9481203125901445;[TLR8]
GO:0002906;negative regulation of mature B cell apoptotic process;11.0;1.0;0.9324289523296623;9.628524252492122;225.7390073925085;8.390779266560578;0.007555281425510346;0.8615337942327104;[CD74, MIF]
GO:0010524;positive regulation of calcium ion transport into cytosol;12.0;0.811012628672052;0.8536266269261705;9.4949928598676;446.85811756486936;5.825829909099042;0.01495593904869991;0.7460535250702665;[CXCL9, THY1, JPH2, CD19, PLCG1, SNCA, TRPC3, CAV1, TRPC1, F2R, CXCL10, P2RX5, CD4, CXCL11, XCL1, CALM3, F2RL3]
GO:2001199;negative regulation of dendritic cell differentiation;8.0;1.0;0.875;9.628524252492122;349.4674446787805;7.9853141584524145;0.01169636087311766;0.7833693374183408;[TMEM176B, TMEM176A, LILRB1, FCGR2B, HLA-G]
GO:0034154;toll-like receptor 7 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.390779266560578;0.013811191226989502;0.8772251544931927;[UNC93B1, TLR7, HAVCR2]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[, NUP107, PHB2, AKT1, HOMER3, WLS, ZFYVE16, NUP85, NUP88, SRP9, MMP12, SNX17, NCF1, CSE1L, TNF, CLU, LAMP2, AP2M1, RAB32, RAB31, SLC27A2, EVI5, BCL6, BCL3, ARL4C, NLGN1, UNC93B1, RAB21, PML, VPS41, IFIT1, ARFIP1, SEC63, EGR2, POLA2, CD24, AKAP12, XPO1, TMED6, SYK, STRADB, RAB33B, NAPA, HSD17B4, STX11, RANBP2, RANBP1, CD74, RANBP6, NEDD4, NUPL2, RAMP1, SCARB2, ZFAND6, TSC2, ATP1B1, HGS, COPB2, TGFB1, NUP155, NFKBIA, TBCK, NUP62, YWHAH, NUP133, TBC1D9, IFNG, EHHADH, NUP54, HSPD1, NUP35, RAN]
GO:0051290;protein heterotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[CD74, NLGN1, RRM1, NUP54]
GO:0002830;positive regulation of type 2 immune response;6.0;0.8933024483968273;0.7697715367885581;9.461470167828956;108.5833891387084;7.069023426578259;0.0036341883157667808;0.6846304993685643;[CD86, CD74, IL33, IL6, RSAD2, RARA, IL18, NLRP3, XCL1, GATA3, NOD2, PRKCZ]
GO:0043030;regulation of macrophage activation;6.0;0.8259837884571596;0.7361122068187242;9.377209824211215;27.112248267214866;6.088194173566533;9.074225500643868E-4;0.63447084575632;[ITGAM, LRRK2, ITGB2, RORA, THBS1, HSPD1, STAP1, HAVCR2, SNCA, IL10, CD74, IL33, MIF, BPI, TLR6, FCGR2B, TLR4, CD200]
GO:0002717;positive regulation of natural killer cell mediated immunity;8.0;0.811012628672052;0.780506314336026;9.461470167828956;317.5703223352917;6.375876246018314;0.010628792893827475;0.701062607729944;[LAG3, SH2D1A, CRTAM, RASGRP1, VAV1, HLA-E, IL18RAP, KLRK1]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[PRF1, ADARB1, IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, PTPRC, BCL2, SERINC5, APOBEC3A, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, ZMYND11, EXOC1, UNC93B1, SAMHD1, IL33, MX2, CARD9, LILRB1, PML]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, CLU, PYCARD, IFIH1, CD36, CCR2, HAVCR2, FCER1G, DDX58, RIPK2, CYBB, MIF, HLA-E, TLR1, IL23A, TLR4, TLR2, PTAFR, LY96, TWIST1, NOD2, THBS1, RASGRP1, CCL19, CD14, FZD5, CARD9, AZU1, CD2, PF4]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, CD74, EDN1, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL23A, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, JAK3, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, RIPK2, IL18, PDCD1LG2, HLA-E, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, CD1D, CORO1A, AIF1, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:0032759;positive regulation of TRAIL production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;85.62186638127122;9.083926447120524;0.0028656868131042177;0.8154717862087246;[HLA-E]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[ITK, PIK3CD, CD3G, PTPN22, RORA, CD3E, CD3D, CCR9, CCR6, SOX4, EOMES, ANXA1, FCER1G, RSAD2, RHOH, RUNX2, VAV1, ZAP70, CLEC4D, LCK, CD8A, KIT, CLEC4E, BLM, TXK, LEF1, TCF7, GATA3, TBX21, NKX2-3, EGR1, TGFB1, BCL11B, FZD5, FZD8, BMX, CD4, PTPRC, MAFB, DNAJA3, BCL3, CD28, BCL2, IL7R, GPR18, IL18R1]
GO:0045581;negative regulation of T cell differentiation;9.0;0.7043150770688792;0.7483981637147287;9.320222892837606;878.9850552837634;6.088194173566533;0.029418838765156156;0.7075911583464645;[CD74, ANXA1, IFNA2, IHH, BCL6, HLX, TBX21, CTLA4, JAK3]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[, IL1RN, CCNH, TCL1A, AKT1, PROK2, TNFSF11, PRKACB, ACSL1, SLC11A1, PRKCD, MIF, EREG, PRKAR1B, IL23A, FPR1, TGFA, PDGFA, IQGAP3, PRKCZ, PIK3R5, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, EGR1, ACE, FZD5, FZD8, EIF2AK2, CDC6, AZU1, PTK2, NOX4, CALM3, CD24, EZH2, CDKN1A, CD40, CCR7, MAP4K1, EDN1, SYK, RIPK2, STRADB, IL18, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD74, CCL21, CENPE, CD40LG, PKN1, CAMK1, CCNT2, NCF1, TNF, CLU, IL6R, PDGFRB, MAP2K2, F2R, ADCYAP1, ADAM9, ADAM8, CSF1R, CALCA, C5AR1, TNFRSF11A, ADRB2, RASGRP1, CCNB1, STAP1, ECT2, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, BMP2, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, ARRB1, CYR61, GHR, GRM5, GREM1, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, NOD2, THBS1, CCL5, FYN, CSK, SNCA, EGF, MAPK14, CD4]
GO:0045582;positive regulation of T cell differentiation;9.0;0.7043150770688792;0.7483981637147287;9.320222892837606;861.1600055729926;5.395046993006588;0.0288222503928399;0.6721435792979885;[CD86, CD83, CD80, IHH, DUSP10, MYB, ANXA1, SYK, RIPK2, IL18, HLA-G, ZAP70, IFNG, IL23A, IL1B, RARA, ADAM8, GATA3, PRKCZ, RASGRP1, HLX, NLRP3, NCKAP1L, CCL19, IL12RB1, CD74, TGFB1, EGR3, LILRB2, VNN1, BCL6, CD27, IL7R]
GO:0001516;prostaglandin biosynthetic process;11.0;0.8933024483968273;0.8790801765280758;9.597752593825367;1037.183190875448;7.138016298065211;0.03471358799433119;0.7974674377644215;[CD74, EDN1, PNPLA8, MGST1, MIF, PTGS2, PTGS1]
GO:0002606;positive regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.28681003950749;7.8311634786251565;0.0018503997771236419;0.7236063770733796;[CD74, CCL21, SLC11A1, CCR7, CCL19, NOD2]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, ETS1, CTGF, RUVBL2, CD38, PDGFRB, IL10, GHSR, POSTN, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, CST3, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:2000566;positive regulation of CD8-positive, alpha-beta T cell proliferation;11.0;1.0;0.9324289523296623;9.628524252492122;1381.573672438919;9.083926447120524;0.0462400274809496;0.8969813732811862;[XCL1, HLA-E]
GO:0001916;positive regulation of T cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.523163736834295;365.14378084230765;6.518977089658987;0.012221033736724321;0.7296214167088868;[HLA-B, HLA-C, CD1E, CD1D, HLA-A, CD1C, HLA-F, CD1B, HLA-G, CD1A, HLA-E, IL23A, XCL1, IL12RB1]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL1RN, TNF, PYCARD, IFIH1, CD36, IL6R, FCER1G, DDX58, RIPK2, F2R, EREG, TLR1, ADCYAP1, IL1A, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, NOD2, HSPD1, IL33, CARD9, LILRB2, MAPK13, IL6, MYD88, IL17A]
GO:0032753;positive regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;6.686031174322154;0.0021737836760178982;0.665044257777226;[CD86, IL33, CEBPB, PRG2, GATA3, CD3E, PRKCZ, HLA-E, CD40LG, CD28, RARA, NLRP3, PRKCQ, HAVCR2]
GO:0036037;CD8-positive, alpha-beta T cell activation;7.0;0.7980440201809971;0.7499413753476991;9.143016436710422;23.590520244074952;7.697632086000634;7.895534824793431E-4;0.7445766281117727;[EOMES, GPR18, HLA-E]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[TGFB1, ABCB4, TNC, PTGS2, CXCL10, CD4, IL1B, SPP1, ALPL, TRIM25]
GO:0060907;positive regulation of macrophage cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;7.9853141584524145;0.010436510936514811;0.8046099625986299;[CD74, CD36]
GO:0045591;positive regulation of regulatory T cell differentiation;10.0;0.8933024483968273;0.861892236059334;9.60254876608886;997.8066164740876;7.292166977892469;0.03339568948573388;0.7881627702307852;[TGFB1, DUSP10, BCL6, IFNG, LILRB2, HLA-G]
GO:0001961;positive regulation of cytokine-mediated signaling pathway;7.0;0.7192862368539868;0.710562483684194;8.965230035081857;244.22079422365863;5.948432231191374;0.008173850198220667;0.6551224661907153;[TXK, GFI1, TREM2, CD74, MED1, EDN1, IL1R1, RIPK2, PARP9, MMP12, IRF7]
GO:0032507;maintenance of protein location in cell;5.0;0.6763753087927167;0.6284286662572787;8.412128928167629;43.86076268124676;5.4730085344763;0.0014679802548176633;0.5701309228349632;[AKT1, TLN1, SP100, EPB41L3, BARD1, GSN, JUP, CAV1, PML, CD4, BCL3]
GO:0045078;positive regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.212124270218933;0.027942676825076673;0.7438283705770736;[TLR8, TLR7]
GO:0050777;negative regulation of immune response;5.0;0.5193749703860713;0.549928497053956;7.293149336675085;78.83017544275083;4.909539177224887;0.0026383750295169523;0.5413150737011212;[IFNA2, TNFAIP3, ARRB2, TNF, LGALS3, DUSP10, DHX58, CTLA4, IL13RA2, JAK3, CCR2, HAVCR2, IL10, CD96, CR1, ANXA1, ARG1, SERPINB9, IRAK3, HLA-G, HLA-E, MMP12, ADCYAP1, CEACAM1, XCL1, SERPING1, CLEC12B, NLRC3, HLX, INPP5D, TBX21, HMOX1, A2M, LYN, IL33, TGFB2, TGFB1, NR1H2, LILRB1, COL3A1, PTPRC, BCL6, PTPN6, FCGR2B, IL7R]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IFI30, OASL, TRIM25, HLA-DPA1, IFNGR1, IFNGR2, PRKCD, HLA-B, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E, HCK, IFNG, OAS1, OAS3, IRF7, HLA-DQB1, CAMK2D, SP100, PTAFR, NCAM1, FCGR1A, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, VCAM1, PML, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[IGHM, HIST1H2BK, SERPINE1, HMGB2, PYCARD, CTSG, IL6R, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, LYZ, SELP, CD4, IL6, IL23A, BPI, TLR4, LTF]
GO:0035691;macrophage migration inhibitory factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;9.777073627680469;0.00101047745553359;0.8509193652572005;[CD74]
GO:0051085;chaperone cofactor-dependent protein refolding;5.0;1.0;0.7902410118609202;9.628524252492122;21.14140270213274;6.409777797693995;7.075837224132252E-4;0.618037346520142;[CD74, HSPA6, HSPE1]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB2, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, SH2D2A, TXK, TGFA, PDGFA, PIK3R3, SLC30A10, PRKCZ, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PILRA, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, GAB2, VAV1, HCK, KIT, PLCB1, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF1, SULF2, NCF1, NCF2, NCF4, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, MATK, TSC2, CYBB, PDGFRL, DOK2, COL4A2, CD8B, KIF16B, COL4A1, CD8A, BLK, CSF1R, CUL5, RASGRP4, FOXO1, SOCS2, STAP1, TGFB1, CAV2, CRIM1, BMX, VIL1, GH1, NR4A3, FES, CSPG4, ITGB3, PIK3C2A, GHR, BLNK, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, CD4, CD7, TEK]
GO:0045356;positive regulation of interferon-alpha biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;8.390779266560578;0.0286306378699575;0.8041048419030481;[TLR8, TLR7]
GO:0002792;negative regulation of peptide secretion;7.0;0.6181399273706679;0.6599893289425345;8.075175806709066;82.49507115094225;4.99795013456894;0.0027610357906781187;0.6065147675675062;[IFNA2, PTPN22, LRRC32, TNF, FAM3D, CD34, IL10, GHSR, ANXA1, RSAD2, IL1R2, F2R, BANK1, IL1B, TLR8, TLR6, NLRP3, DRD4, CD74, IL33, FN1, NR1H4, LILRB1, PML, NLRP12, FKBP1B, FCGR2B, LGR4]
GO:0045359;positive regulation of interferon-beta biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;7.8311634786251565;0.0286306378699575;0.7754860644832351;[TLR8, TLR7]
GO:0060337;type I interferon signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.587418885654044;0.00101047745553359;0.6366602269110988;[IFNA5, IFNA4, IFNA7, SP100, IFNA2, IFI6, SAMHD1, IFIT1, IFNA8, IFIT3, IFIT2, OASL, IFNA21, EGR1, IFNA14, RSAD2, IFNA16, MX2, HLA-B, HLA-C, ISG15, HLA-A, HLA-F, HLA-G, HLA-E, IFI27, OAS1, OAS3, IRF7, MYD88, IFNA10]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD86, IL1A, CD4, CD80, IL1B, CD28, PRKCQ, CD3E, CARD11]
GO:0002666;positive regulation of T cell tolerance induction;7.0;0.8653626801206646;0.7836007053175329;9.4949928598676;165.82106058012107;7.8311634786251565;0.005549881668350914;0.7514054297404357;[LILRB2, CD3E, HLA-G]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[CD40, HSPD1, CCR7, CD36, CCL19, RIPK2, MAPK14, HLA-G, CD40LG, IFNG, IL23A, LTB, PLCB1, TLR4, TLR2]
GO:0032736;positive regulation of interleukin-13 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;7.069023426578259;0.002183412136085803;0.6846304993685643;[IL33, RARA, NLRP3, GATA3, PRKCZ, IL17RB, HLA-E]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[CD86, CD274, CEBPB, CD80, IHH, LRRC32, GPNMB, CTLA4, HAVCR2, IL10, TGFB1, ARG1, PAWR, LILRB1, PDCD1LG2, LILRB2, HLA-G, XCL1, PTPN6, PDE5A, MAD1L1]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, RNASE6, RNASE3, MIF, HLA-E, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, RIPK2, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, IGKC, CARD9, NR1H4, KIR3DL1, LGR4, C1QC, FCN1, NCF1, NCF2, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PDGFD, PDGFC, SLAMF1, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, ARRB1, ARRB2, CCR7, CD36, HAVCR2, RIPK2, IL1B, KIT, XCL2, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0035723;interleukin-15-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.212124270218933;0.00101047745553359;0.7197477358342742;[IL2RG, CD4, IL2RB, PLCB1, JAK3]
GO:2000343;positive regulation of chemokine (C-X-C motif) ligand 2 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;89.02652997090885;7.8311634786251565;0.0029796378394510905;0.7514054297404357;[CD74, POSTN, MIF, TNF]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, EDN1, DAPK1, KIF16B, XCL2, XCL1, TLR4, TLR2, CCL13, STXBP2, AIF1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, ZYX]
